Skip to content

Booksellers & Trade Customers: Sign up for online bulk buying at trade.atlanticbooks.com for wholesale discounts

Booksellers: Create Account on our B2B Portal for wholesale discounts

Intraperitoneal Therapy for Ovarian Cancer

by David Alberts
Sold out
Current price ₹9,839.00
Original price ₹14,055.00
Original price ₹14,055.00
Original price ₹14,055.00
(-30%)
₹9,839.00
Current price ₹9,839.00

Imported Edition - Ships in 18-21 Days

Free Shipping in India on orders above Rs. 500

Request Bulk Quantity Quote
+91
Book cover type: Paperback
  • ISBN13: 9783642423574
  • Binding: Paperback
  • Subject: N/A
  • Publisher: Springer
  • Publisher Imprint: Springer
  • Publication Date:
  • Pages: 153
  • Original Price: EUR 139.99
  • Language: English
  • Edition: 2010
  • Item Weight: 243 grams
  • BISAC Subject(s): Oncology / General

From the Back Cover
Intraperitoneal chemotherapy is increasingly being used as first-line treatment for ovarian cancer. Nevertheless, it is difficult for the oncologist to find a definitive text that documents both the fundamental methods required to optimize therapy and the up-to-date results of phase I, II, and III clinical trials. With this in mind, the editors of Intraperitoneal Therapy for Ovarian Cancer have assembled a team of highly experienced clinicians and researchers to cover every aspect of the subject. The topics addressed include treatment principles, patient, drug, and catheter selection, administration guidelines, the role of hyperthermia, supportive care requirements, novel drugs, and the most recent results of clinical trials. This book will be an invaluable source of information for both practicing clinical oncologists and oncologists in training, oncologists and basic and translational scientists in training.

Prof. Alberts is Director of the Arizona Cancer Center in Tucson, AZ. He led a workshop on intraperitoneal chemotherapy in January 2006 at the Gynecologic Oncology Group meeting with 400 oncologists and nurses present. He also published the results of the first ever phase III trial comparing IV to IP chemotherapy in the New England Journal of Medicine.

Trusted for over 49 years

Family Owned Company

Secure Payment

All Major Credit Cards/Debit Cards/UPI & More Accepted

New & Authentic Products

India's Largest Distributor

Need Support?

Whatsapp Us